Global Surgical Tumor Ablation Market Is Expected To Reach Around USD 2,256 Million By 2025

Zion Market Research has published a new report titled “Surgical Tumor Ablation Market by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Others) and by Application (Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global surgical tumor ablation market was approximately USD 1,044 million in 2018 and is expected to generate around USD 2,256 million by 2025, at a CAGR of around 11.6% between 2019 and 2025.

Tumor ablation is referred to as a minimally-invasive technique for the treatment or destruction of cancer cells. Certain probes like needles are used to freeze or burn cancerous cells without conventional surgical treatment. Increasing prevalence of cancer across the globe is creating the demand for an efficient and effective treatment that can improve patient health at a relatively lower time, with minimal invasion and pain and at affordable costs. This is the primary growth driver of the global surgical tumor ablation market. Other prominent factors boosting the surgical tumor ablation market growth are the rising awareness about the advantages of tumor ablation over conventional treatment methods and growing investments made in tumor ablation techniques worldwide. Furthermore, technological advancements related to the thermal ablation technique are also expected to fuel the surgical tumor ablation market growth in the upcoming years. However, the change in government reforms may hinder the global surgical tumor ablation market growth in the years ahead.

Browse the full “Surgical Tumor Ablation Market by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Others) and by Application (Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/surgical-tumor-ablation-market

The global surgical tumor ablation market is fragmented on the basis of technology and application. Based on technology, the market includes cryoablation, microwave ablation, radiofrequency ablation, and others. By technology, the microwave ablation segment is expected to register the highest growth rate in the future, due to product-related technological advancements and benefits like consistency in high temperature, lower procedural pain, larger tumor ablation volume, and optimal heating of the cystic mass.

By application, the global surgical tumor ablation market is categorized into lung cancer, prostate cancer, breast cancer, liver cancer, and others. The liver cancer segment is estimated to hold a notable market share in the future, whereas the lung cancer segment is expected to show a high CAGR over the forecast time period. According to the American Cancer Society Liver, cancer is one of the most common diseases in Southeast Asia and sub-Saharan Africa than in the U.S. More than 700,000 people are diagnosed with liver cancer annually across the globe. Liver cancer is a major root of cancer deaths globally, accounting for more than 600,000 deaths every year.

The North American surgical tumor ablation market is anticipated to continue its regional dominance over the forecast timeframe as well. This can be attributed to Well-planned and implemented healthcare reforms, high adoption of advance therapeutic procedure, increasing prevalence of cancer, and high purchasing power of the regional population. The Asia Pacific surgical tumor ablation market is proposed to register the highest growth rate over the projected timeframe, owing to the increasing cancer prevalence, rising disposable income of the regional population, and a growing number of government initiative with favorable reimbursement policies.

Some key players of the global surgical tumor ablation market are Galil Medical, Misonix, HealthTronics, AngioDynamics, Covidien, Boston Scientific Corporation, Medtronic, SonaCare Medical, EDAP TMS, and NeuWave Medical.

This report segments the global surgical tumor ablation market into:

Global Surgical Tumor Ablation Market: Technology Analysis

• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• Others

Global Surgical Tumor Ablation Market: Application Analysis

• Liver Cancer
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Others

Global Surgical Tumor Ablation Market: Regional Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com